YOLFTbeta
Handok

Handok

002390 · KO · Healthcare / Drug Manufacturers - Specialty & Generic

8,240.00KRW-20.00 (-0.24%)

Price History

Full chart

Market Stats

Previous Close8,260.00
Open8,240.00
Day Range8,190.00 – 8,370.00
52-Week Range6,460.00 – 11,943.37
Volume951
Market Cap109.51B
P/E (TTM)0.00
Forward P/E11.45
Dividend Yield2.37%
Beta0.19
50-Day Avg9,115.00
200-Day Avg9,763.65

About

HANDOK Inc. operates as a pharmaceutical company. The company provides prescription and OTC drugs; medical devices, such as blood pressure monitors, cholesterol monitoring systems, insulin pumps, self-monitoring system of blood glucose, and blood glucose monitoring system; in vitro diagnostic medical devices; as well as life science products. It also offers healthcare products comprising food supplements under the NatureSet brand; food and beverages; and medical nutrition products. In addition, the company engages in real estate leasing. The company was formerly known as Handok Pharmaceuticals Co., Ltd and changed its name to Handok Inc. in July 2013. Handok Inc. was founded in 1954 and is headquartered in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Young-Jin Kim M.B.A.
  • Employees908
  • Headquarters132 Teheran-ro, Seoul, South Korea, 06235, Korea
  • Websitehttps://www.handok.co.kr

Leadership

  • Mr. Young-Jin Kim M.B.A.Chairman & CEO · b. 1956
  • Ms. Jeong-yol ChoPresident
  • Ms. Miyeon KimPresident, Director & COO
  • Jin Ki BaekVice President & Executive Director

Financials

Income Statement

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue333.17B314.65B327.94B348.31B358.45B396.13B417.97B446.73B473.00B503.61B517.64B543.76B522.74B507.36B535.14B
Growth (%)--5.56%+4.22%+6.21%+2.91%+10.51%+5.51%+6.88%+5.88%+6.47%+2.79%+5.05%-3.87%-2.94%+5.48%
Cost of Revenue203.70B208.98B222.30B233.91B238.21B268.62B285.11B288.96B307.00B335.22B350.09B370.05B356.39B349.94B376.21B
Gross Profit--99.12B114.40B120.24B127.51B132.86B157.77B166.00B168.39B167.55B173.71B166.35B157.41B158.93B
Gross Margin--30.23%32.84%33.54%32.19%31.79%35.32%35.09%33.44%32.37%31.95%31.82%31.03%29.70%
Operating Expense--91.66B104.08B114.02B123.87B134.73B135.69B138.53B140.01B139.54B145.22B153.77B156.88B155.64B
Operating Income21.43B8.60B7.46B10.31B6.22B3.64B-1.87B22.08B27.47B28.38B28.01B28.50B12.58B538.51M3.29B
Operating Margin6.43%2.73%2.28%2.96%1.74%0.92%-0.45%4.94%5.81%5.63%5.41%5.24%2.41%0.11%0.62%
EBITDA------29.98B35.12B76.68B70.34B31.90B37.30B2.76B-20.82B35.51B
EBITDA Margin------7.17%7.86%16.21%13.97%6.16%6.86%0.53%-4.10%6.64%
Net Income16.57B5.77B12.31B1.47B-1.69B-6.45B4.87B7.99B34.93B26.96B3.29B10.68B-28.80B-52.56B-2.15B
Net Income Margin4.97%1.83%3.75%0.42%-0.47%-1.63%1.16%1.79%7.38%5.35%0.64%1.96%-5.51%-10.36%-0.40%
R&D16.10B13.25B17.91B15.63B18.81B18.47B22.45B21.12B19.24B20.13B22.88B24.00B28.67B22.63B21.19B
R&D as % of Total Revenue4.83%4.21%5.46%4.49%5.25%4.66%5.37%4.73%4.07%4.00%4.42%4.41%5.48%4.46%3.96%
Interest Expense00000005.86B6.63B6.76B5.76B8.23B13.78B17.30B19.51B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%1.31%1.40%1.34%1.11%1.51%2.64%3.41%3.65%

Balance Sheet

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets408.21B436.39B473.53B515.49B530.59B622.85B639.35B652.62B748.67B818.93B841.56B871.11B790.34B788.56B790.75B
Total Liabilities129.88B149.14B179.25B207.71B226.88B333.60B348.63B339.24B404.67B437.08B457.57B489.25B449.71B499.49B512.43B
Total Equity278.34B287.25B294.28B307.77B298.48B280.87B284.29B307.38B340.74B381.30B384.00B379.81B338.73B287.26B276.61B
Cash1.46B860.75M1.83B6.44B11.03B11.85B34.76B32.50B17.99B23.70B30.44B36.85B16.56B53.04B25.07B
Net Debt------154.19B125.92B195.66B208.40B226.51B260.20B281.74B318.44B351.93B

Cash Flow

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow48.08B12.28B9.28B36.56B14.64B-8.50B6.79B29.46B8.80B24.34B37.23B30.52B35.98B-2.79B3.98B
Investing Cash Flow---20.70B-78.46B-22.23B-63.78B-2.54B-18.29B-79.13B-27.77B-45.70B-63.50B---
Financing Cash Flow-38.83B12.39B46.00B12.17B73.10B18.74B-13.45B55.74B9.21B15.25B39.83B---
Capital Expenditure21.32B14.39B11.88B12.00B12.68B31.69B29.15B15.77B22.03B20.44B43.02B36.20B26.18B19.40B15.84B
Free Cash Flow-------33.96B7.86B-17.23B1.67B-6.23B-13.22B9.80B-22.19B-11.86B
Dividends Paid6.15B2.90B1.74B2.32B1.87B1.24B1.56B3.30B6.13B3.78B4.13B4.82B5.51B4.13B2.75B
FCF to OCF-------500.14%26.70%-195.78%6.88%-16.73%-43.32%27.24%795.93%-297.69%
Dividend Paid to FCF-------4.58%41.95%-35.57%226.05%-66.28%-36.44%56.17%-18.61%-23.22%

Earnings

Report DateJun 3, 2009Sep 2, 2009Dec 2, 2009Mar 3, 2010Jun 1, 2011Aug 31, 2011Nov 30, 2011Feb 29, 2012May 30, 2012Aug 29, 2012Nov 28, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Aug 14, 2014Nov 12, 2014Feb 12, 2015Apr 30, 2015Jul 31, 2015Oct 30, 2015Feb 1, 2016May 10, 2016Aug 1, 2016Oct 31, 2016Feb 9, 2017Apr 27, 2017Aug 1, 2017Oct 31, 2017Feb 8, 2018May 1, 2018Jul 31, 2018Oct 30, 2018Feb 12, 2019Aug 28, 2019Nov 13, 2019Feb 6, 2020Apr 23, 2020Aug 4, 2020Nov 11, 2020Mar 17, 2021May 13, 2021Aug 13, 2021Oct 30, 2021Mar 13, 2022Apr 28, 2022Jul 28, 2022Oct 26, 2022Feb 9, 2023May 12, 2023Aug 11, 2023Nov 2, 2023Feb 6, 2024May 14, 2024Aug 13, 2024Nov 13, 2024Mar 11, 2025May 15, 2025Jul 31, 2025Oct 29, 2025Feb 3, 2026Apr 28, 2026Jun 30, 2026
EPS Estimate-----------------------------------------------------------------
EPS Actual200.00390.30371.34574.53464.58437.34287.94224.16235.9224.56192.9938.6629.77-30.7233.651017.51411.70-73.00-95.44-99.03-306.52-189.76-178.71539.4622.30-277.32-145.76-117.70-242.25-216.57358.30491.63394.007.37325.41-135.86-393.161226.601215.57-50.3877.961040.14891.05138.24216.11-155.5040.5324.97-113.16290.00573.05-316.03-441.97-223.17-1111.13-163.56-935.93-289.72-2429.78-558.39-489.67304.16611.37-657.96-978.80
Surprise-----------------------------------------------------------------
Timing-----------------Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-market-------After-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-market-Pre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketPre-marketPre-market-

Key Statistics & Ratios

Market Cap109.51B
Enterprise Value459.72B
Trailing P/E0.00
Forward P/E11.45
PEG Ratio0.00
Price / Sales0.20
Price / Book0.43
Revenue (TTM)560.89B
Gross Profit (TTM)165.65B
EBITDA31.84B
Profit Margin-1.67%
Operating Margin1.97%
Return on Equity-3.65%
Return on Assets0.66%
Shares Outstanding12.99M
Shares Float7.18M
Beta0.19
Dividend Yield2.37%
Dividend Rate200.00
Payout Ratio0.00%

Dividends

20261×
200.00Feb 26, 2026
20251×
200.00Feb 27, 2025
20231×
300.00Dec 27, 2023
20221×
400.00Dec 28, 2022
20211×
350.00Dec 29, 2021
20201×
300.00Dec 29, 2020
20191×
275.00Dec 27, 2019
20181×
450.00Dec 27, 2018
20171×
265.00Dec 27, 2017
20161×
125.00Dec 28, 2016
20151×
100.00Dec 29, 2015
20141×
150.00Dec 29, 2014
20131×
197.93Dec 27, 2013
20121×
148.45Dec 27, 2012
20112×
247.42Dec 28, 2011148.45Jun 29, 2011
20102×
376.07Dec 29, 2010148.45Jun 29, 2010
20092×
385.97Dec 29, 200974.22Jun 29, 2009
20082×
59.38Dec 29, 200898.97Jun 27, 2008
20072×
346.38Dec 27, 2007148.45Jun 28, 2007

Stock Splits

  • May 2, 200310:1